US Stock MarketDetailed Quotes

TFFP TFF Pharmaceuticals

Watchlist
  • 2.0900
  • -0.1100-5.00%
Close May 8 16:00 ET
  • 2.0900
  • 0.00000.00%
Post 17:45 ET
8.75MMarket Cap-176P/E (TTM)

About TFF Pharmaceuticals Company

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.

Company Profile

SymbolTFFP
Company NameTFF Pharmaceuticals
Listing DateOct 25, 2019
Issue Price5.00
Founded2018
CEODr. Harlan F. Weisman, M.D.
MarketNASDAQ
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1751 River Run,Suite 400
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76107
Phone1-817-438-6168
Websitehttp://www.tffpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Harlan F. Weisman, M.D.
  • President, Chief Executive Officer and Director
  • 2.08M
  • Dr. Zamaneh Mikhak
  • Chief Medical Officer
  • 860.51K
  • Kirk Coleman
  • Chief Financial Officer and Principal Accounting Officer
  • 469.07K
  • Brandi L. Roberts
  • Independent Director
  • 70.92K
  • Dr. Michael Patane, PhD
  • Independent Director
  • 41.85K
  • Catherine C. Lee, J.D.
  • Independent Director
  • 41.85K
  • Thomas Braxton King
  • Independent Director
  • 38.41K
  • Stephen C. Rocamboli
  • Independent Director
  • 67.88K
  • Robert S. Mills, Jr
  • Independent Director
  • 144.53K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg